Charles Ryhee
Stock Analyst at TD Cowen
(2.43)
# 2,460
Out of 5,152 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $78.69 | +1.66% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $931.35 | -29.99% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $189.90 | -10.48% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $3.40 | +1,635.29% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $216.02 | -66.67% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $5.12 | +3,571.88% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $14.39 | +101.53% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $78.69
Upside: +1.66%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $931.35
Upside: -29.99%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $189.90
Upside: -10.48%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $3.40
Upside: +1,635.29%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $216.02
Upside: -66.67%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $5.12
Upside: +3,571.88%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $14.39
Upside: +101.53%